- Home
- PCB vs PRQR Comparison
PCB vs PRQR Comparison
Compare PCB & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCB
- PRQR
- Stock Information
- Founded
- PCB 2003
- PRQR 2012
- Country
- PCB United States
- PRQR Netherlands
- Employees
- PCB N/A
- PRQR N/A
- Industry
- PCB Major Banks
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- PCB Finance
- PRQR Health Care
- Exchange
- PCB Nasdaq
- PRQR Nasdaq
- Market Cap
- PCB 291.1M
- PRQR 179.1M
- IPO Year
- PCB N/A
- PRQR 2014
- Fundamental
- Price
- PCB $21.00
- PRQR $2.04
- Analyst Decision
- PCB Hold
- PRQR Strong Buy
- Analyst Count
- PCB 2
- PRQR 8
- Target Price
- PCB $22.00
- PRQR $8.88
- AVG Volume (30 Days)
- PCB 33.7K
- PRQR 355.0K
- Earning Date
- PCB 07-24-2025
- PRQR 08-07-2025
- Dividend Yield
- PCB 3.82%
- PRQR N/A
- EPS Growth
- PCB 11.00
- PRQR N/A
- EPS
- PCB 1.94
- PRQR N/A
- Revenue
- PCB $98,720,000.00
- PRQR $21,212,711.00
- Revenue This Year
- PCB $20.01
- PRQR N/A
- Revenue Next Year
- PCB $9.23
- PRQR N/A
- P/E Ratio
- PCB $10.80
- PRQR N/A
- Revenue Growth
- PCB 5.07
- PRQR 85.91
- 52 Week Low
- PCB $15.03
- PRQR $1.07
- 52 Week High
- PCB $22.20
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- PCB 61.66
- PRQR 71.54
- Support Level
- PCB $20.41
- PRQR $1.89
- Resistance Level
- PCB $21.17
- PRQR $2.20
- Average True Range (ATR)
- PCB 0.47
- PRQR 0.11
- MACD
- PCB 0.11
- PRQR 0.02
- Stochastic Oscillator
- PCB 82.23
- PRQR 90.70
About PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.